Gamma-oryzanol as a potential intervention for normalizing insulin secretion and pancreatic β-cell function
Main Article Content
Abstract
The bioactive substance gamma-oryzanol (GO), which is mostly present in rice bran oil, has attracted a lot of interest due to its possible therapeutic application in metabolic conditions like diabetes mellitus. The effects of GO on insulin secretion and pancreatic β-cell function are examined in this study. Gamma-oryzanol improves β-cell viability, lowers oxidative stress, and modifies intracellular signaling pathways linked to glucose metabolism, all of which increase insulin secretion, according to experimental and clinical evidence. Additionally, GO's anti-inflammatory and antioxidant qualities shield β-cells from dysfunction and apoptosis brought on by hyperglycemia and lipid toxicity. Relevant studies were identified through a systematic search of PubMed, ScienceDirect, and Google Scholar for articles published between 2017 and 2026 using the keyword “gamma-oryzanol”, “insulin secretion”, ‘pancreatic β-cell function”. Additionally, the substance seems to support glucose homeostasis and pancreatic function by upregulating important genes involved in insulin synthesis and secretion. All things considered, GO shows great promise as a natural agent for maintaining β-cell integrity and increasing insulin secretion, providing a novel complementary approach to managing diabetes. Gamma-oryzanol is frequently linked to anti-inflammatory, anti-cancer, anti-diabetic, and cholesterol-lowering properties. Because Orz reduces insulin activity, cholesterol metabolism, and associated chronic inflammation, its potential to treat metabolic diseases has recently been investigated. After apoptosis and increased endoplasmic reticulum (ER) stress were decreased, oral GO administration increased glucose-stimulated insulin secretion in islets from diabetic mice fed a high-fat diet. We also examined the effects of GO on low-dose streptozotocin-induced diabetic mice, which demonstrated elevated ER stress and consequent β-cell apoptosis. Furthermore, γ-oryzanol improved glucose dysmetabolism in this model by lowering the mRNA levels of genes linked to apoptotic signaling and ER stress in islets. All things considered, GO shows encouraging potential as a natural agent for enhancing insulin secretion and maintaining the integrity of β-cells, providing a new complementary strategy for controlling and preventing diabetes.
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.
How to Cite
References
1. Dludla PV, Mabhida SE, Ziqubu K, et al. Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress. World J Diabetes 2023;14:130-46. doi: 10.4239/wjd. v14.i3.130.
2. Hossain MJ, Al-Mamun M, Islam MR. Diabetes mellitus, the fastest growing global public health concern: early detection should be focused. Health Sci Rep 2024;7:e2004. doi: 10.1002/hsr2.2004.
3. Leenders F, Groen N, de Graaf N, et al. Oxidative stress leads to β-cell dysfunction through loss of β-cell identity. Front Immunol 2021;12:690379. doi: 10.3389/fimmu.2021.690379.
4. Smoak P, Burke SJ, Collier JJ. Botanical interventions to improve glucose control and options for diabetes therapy. SN Compr Clin Med 2021;3:2465-91. doi: 10.1007/s42399-021-01034-8.
5. Lu X, Xie Q, Pan X, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther 2024;9: 262. https://doi.org/10.1038/s41392-024-01951-9.
6. Sun HY, Lin XY. Analysis of the management and therapeutic performance of diabetes mellitus employing special target. World J Diabetes 2023; 14:1721-37. doi: 10.4239/wjd. v14.i12.1721.
7. Juricic H, Cuccioloni M, Bonfili L, et al. Biochemical, biological, and clinical properties of γ-oryzanol. Antioxidants (Basel) 2025;14:1099. doi: 10.3390/antiox14091099.
8. Maache S, Laaroussi H, Soulo N, et al. The antioxidant, antidiabetic, and antihyperlipidemic effects of the polyphenolic extract from Salvia blancoana subsp. mesatlantica on induced diabetes in rats. Bioresour. Bioprocess 2024;11: 62. doi: 10.1186/s40643-024-00769-1. Erratum in: Bioresour Bioprocess 2024;11:71. doi: 10.1186/s40643-024-00780-6.
9. González P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an Iitegral, updated and critical overview of their metabolic interconnections. Int J Mol Sci 2023;24:9352. doi: 10.3390/ijms24119352.
10. Radda MI, Omar N, Yusof SFM, et al. Effectiveness of gamma-oryzanol in glycaemic control and managing oxidative stress, inflammation, and dyslipidaemia in diabetes: a systematic review of preclinical studies. Peer J 2025;13:e20062. doi: 10.7717/peerj.20062.
11. Radda MI, Omar N, Ahmad R, et al. Gamma-oryzanol: a novel promising supplement for diabetes mellitus. Univ Med 2025;44:90-100. https://doi.org/10.18051/UnivMed.2025.v44.90-100.
12. Rungratanawanich W, Cenini G, Mastinu A, et al. γ-Oryzanol improves cognitive function and modulates hippocampal proteome in mice. Nutrients 2019;11:753. doi: 10.3390/nu11040753.
13. Zhang X, Deng D, Cui D, et al. Cholesterol sulfate exerts protective effect on pancreatic β-cells by regulating β-cell mass and insulin secretion. Front Pharmacol 2022;13:840406. doi: 10.3389/fphar.2022.840406.
14. Deepa Maheshvare M, Raha S, König M, Pal D. A pathway model of glucose-stimulated insulin secretion in the pancreatic β-cell. Front Endocrinol (Lausanne) 2023;14:1185656. doi: 10.3389/fendo.2023.1185656.
15. Musapoor S, Davoodian N, Kadivar A, Ahmadi E, Nazari H. Media supplementation with gamma-oryzanol improves the outcome of ovine oocyte maturation in vitro. Vet Med Sci 2025;11: e70134. doi: 10.1002/vms3.70134.
16. Sugandh F, Chandio M, Raveena F, et al. Advances in the management of diabetes mellitus: a focus on personalized medicine. Cureus 2023;15:e43697. doi: 10.7759/cureus.43697.
17. Lee D, Kim SJ, Choi YJ, et al. The glucose-lowering effect of Mesembryanthemum crystallinum and D-pinitol: studies on insulin secretion in INS-1 cells and the reduction of blood glucose in diabetic rats. Nutrients 2025;17:193. https://doi.org/10.3390/nu17010193.
18. Acosta-Montalvo A, Saponaro C, Kerr-Conte J, Prehn JHM, Pattou F, Bonner C. Proglucagon-derived peptides expression and secretion in rat insulinoma INS-1 cells. Front Cell Dev Biol 2020; 8:590763. doi: 10.3389/fcell.2020.590763.
19. Mazloum-Ardakani M, Barazesh B, Moshtaghioun SM, Sheikhha MH. Designing and optimization of an electrochemical substitute for the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability assay. Sci Rep 2019;9:14966. doi: 10.1038/s41598-019-51241-6.
20. Molano RD, Pileggi A, Tse HM, Stabler CL, Fraker CA. A static glucose-stimulated insulin secretion (sGSIS) assay that is significantly predictive of time to diabetes reversal in the human islet bioassay. BMJ Open Diabetes Res Care 2024;12:e003897. doi: 10.1136/bmjdrc-2023-003897.
21. Newsholme P, Keane KN, Carlessi R, Cruzat V. Oxidative stress pathways in pancreatic β-cells and insulin-sensitive cells and tissues: importance to cell metabolism, function, and dysfunction. I am J Physiol Cell Physiol 2019;317:C420-C33. doi: 10.1152/ajpcell.00141.2019.
22. Chen X, Xie N, Feng L, et al. Oxidative stress in diabetes mellitus and its complications: from pathophysiology to therapeutic strategies. Chin Med J (Engl.) 2025;138:15-27. DOI: 10.1097/CM9.0000000000003230.
23. Sknepnek A, Miletić D, Stupar A, Salević-Jelić A, Nedović V, Cvetanović Kljakić A. Natural solutions for diabetes: the therapeutic potential of plants and mushrooms. Front Nutr 2025; 12:1511049. doi: 10.3389/fnut.2025.1511049.
24. Youssef MM, El-Yamany MF, Abdel-Kader RM, Heikal OA. Rice bran extract attenuates cognitive impairment by enhancing pancreatic β-cell insulin secretion in STZ-induced diabetic rats targeting the PPARγ/PDX1 pathway. Metab Brain Dis 2025;40:228. doi: 10.1007/s11011-025-01639-1.
25. Rungratanawanich W, Abate G, Serafini MM, et al. Characterization of the antioxidant effects of γ-Oryzanol: involvement of the Nrf2 pathway. Oxid Med Cell Longev 2018;2018:2987249. doi: 10.1155/2018/2987249.
26. Ordóñez-Díaz MD, Gil-Campos M, Flores-Rojas K, et al. Impaired antioxidant defence status is associated with metabolic-inflammatory risk factors in preterm children with extrauterine growth restriction: the BIORICA cohort study. Front Nutr 2021;8:793862. doi: 10.3389/fnut.2021.793862.
27. Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 2018;19:121-35. doi: 10.1038/nrm.2017.95.
28. Kozuka C, Sunagawa S, Ueda R, et al. A novel insulinotropic mechanism of whole grain-derived γ-oryzanol via the suppression of local dopamine D2 receptor signalling in mouse islet. Br J Pharmacol 2015;172:4519-34. doi: 10.1111/bph.13236.
29. Beaupere C, Liboz A, Fève B, Blondeau B, Guillemain G. Molecular mechanisms of glucocorticoid-induced insulin resistance. Int J Mol Sci 2021; 22:623. https://doi.org/10.3390/ijms22020623
30. Manzoor A, Pandey VK, Dar AH, et al. Rice bran: nutritional, phytochemical, and pharmacological profile and its contribution to human health promotion. Food Chem Adv 2023; 2:100296. https://doi.org/10.1016/j.focha.2023.100296.
31. Yesupatham A, Saraswathy R. Role of oxidative stress in prediabetes development. Biochem Biophys Rep 2025;43:102069. doi: 10.1016/j.bbrep.2025.102069.
32. Gusti AMT, Qusti SY, Alshammari EM, Toraih EA, Fawzy MS. Antioxidants-related superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), glutathione-S-transferase (GST), and nitric oxide synthase (NOS) gene variants analysis in an obese population: a preliminary case-control study. Antioxidants (Basel) 2021;10:595. doi: 10.3390/antiox10040595.
33. Pedersen SS, Prause M, Williams K, Barrès R, Billestrup N. Butyrate inhibits IL-1β-induced inflammatory gene expression by suppression of NF-κB activity in pancreatic beta cells. J Biol Chem 2022;298:102312. doi: 10.1016/j.jbc.2022.102312.
34. Grubelnik V, Zmazek J, Završnik M, Marhl M. Lipotoxicity in a vicious cycle of pancreatic beta cell exhaustion. Biomedicines 2022; 10:1627. https://doi.org/10.3390/biomedicines10071627.
35. Semwal DK, Kumar A, Aswal S, Chauhan A, Semwal RB. Protective and therapeutic effects of natural products against diabetes mellitus via regenerating pancreatic β-cells and restoring their dysfunction. Phytother Res 2021;35:1218-29. doi: 10.1002/ptr.6885.
36. Wang J, Wang H. Oxidative stress in pancreatic beta cell regeneration. Oxid Med Cell Longev 2017;2017:1930261. doi: 10.1155/2017/1930261.
37. Oh YS, Bae GD, Baek DJ, Park EY, Jun HS. Fatty acid-induced lipotoxicity in pancreatic beta-cells during development of type 2 diabetes. Front Endocrinol (Lausanne) 2018;9:384. doi: 10.3389/fendo.2018.00384.
38. Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J 2022;46:15-37. doi: 10.4093/dmj.2021.0280.
39. Weiser A, Feige JN, De Marchi U. Mitochondrial calcium signaling in pancreatic β-cell. Int J Mol Sci 2021;22:2515. doi: 10.3390/ijms22052515.
40. Röder P, Wu B, Liu Y, et al. Pancreatic regulation of glucose homeostasis. Exp Mol Med 2016;48, e219. https://doi.org/10.1038/emm.2016.6.
41. Campbell JE, Newgard CB. Mechanisms control pancreatic islet cell function in insulin secretion. Nat Rev Mol Cell Biol 2021;22:142-58. doi: 10.1038/s41580-020-00317-7.
42. Ma J, Li M, Yang L, et al. Pancreatic islet cell hormones: secretion, function, and diabetes therapy. Med Comm (2020) 2025;6:e70359. doi: 10.1002/mco2.70359.
43. Da Silva Xavier G. The cells of the islets of Langerhans. J Clin Med 2018;7:54. doi: 10.3390/jcm7030054.
44. Vargas E, Joy NV, Carrillo Sepulveda MA. Biochemistry, insulin metabolic effects. Treasure Island (FL): StatPearls Publishing; 2025.
45. Sun B, Chen H, Xue J, Li P, Fu X. The role of GLUT2 in glucose metabolism in multiple organs and tissues. Mol Biol Rep. 2023;50:6963-74. doi: 10.1007/s11033-023-08535-w.
46. Kamel-ElSayed SA, Mukherjee S. Physiology, pancreas. Treasure Island (FL): StatPearls Publishing; 2025.
47. Rorsman P, Ashcroft FM. Pancreatic β-cell electrical activity and insulin secretion of mice and men. Physiol Rev 2018; 98:117-214. doi: 10.1152/physrev.00008.2017.
48. Scarl RT, Corbin KL, Vann NW, et al. Intact pancreatic islets and dispersed beta-cells both generate intracellular calcium oscillations but differ in their responsiveness to glucose. Cell Calcium 2019;83:102081. doi: 10.1016/j.ceca.2019.102081.
49. Caspi I, Tremmel DM, Pulecio J, et al. Glucose transporters are key components of the human Glucostat. Diabetes 2024;73:1336-51. doi: 10.2337/db23-0508.
50. Trexler AJ, Taraska JW. Regulation of insulin exocytosis by calcium-dependent protein kinase C in beta cells. Cell Calcium 2017;67:1-10. doi: 10.1016/j.ceca.2017.07.008.
51. Marinelli I, Fletcher PA, Sherman AS, Satin LS, Bertram R. Symbiosis of electrical and metabolic oscillations in pancreatic β-cells. Front Physiol 2021;12:781581. doi: 10.3389/fphys.2021.781581.
52. Briggs JK, Gresch A, Marinelli I, et al. β-cell intrinsic dynamics rather than gap junction structure dictates subpopulations in the islet functional network. eLLife 2023 ;12: e83147. doi: 10.7554/eLife.83147.